Medibank Private Leans Into Preventative Health As Claims Costs Bite

Fund managers track a murky claims picture against a growing push into medical clinics and at-home care

4 May 2026 · 6 min read

A regulatory change gave Medibank Private a boost in April 2026. Alliance Bernstein reported its overweight position contributed to performance as investors reacted positively to the removal of age-based rebates for older, higher-claiming cohorts, a change viewed as supportive for the company's claims cost outlook. The manager said it continues to believe Medibank is well positioned to deliver resilient earnings growth, underpinned by its leading market position, disciplined pricing and strong capital position. Antares Capital made a related point the same month, noting the stock had regained investor interest after underperforming earlier in the calendar year, supported by its valuation appeal, defensive earnings profile, and status as a beneficiary of rising interest rates through its investment portfolio.

A result made opaque by an accounting transition

That regulatory tailwind followed a genuinely murky February 2026 half-year result. Pendal Group reported the stock rallied 6 per cent the day before results on news of a strong 5.1 per cent premium increase, above the 4.4 per cent industry average, only to give those gains back once the result showed why the higher pricing had been necessary. Revenue mix headwinds deteriorated 50 basis points to 1.5 per cent and cash claims per policy rose 3.5 per cent, together fully accounting for the 5 per cent pricing increase, leaving margins stable but with no obvious buffer to absorb further industry or political headwinds. The manager said the cash flow statement suggested cash claims might be under even more pressure than first appeared, a discrepancy management attributed to faster claim settlements, alongside signs of conservatism including extended benefit limits on some policies and increased hospital indexation.

MPL results are typically strong and clean, but this result was more opaque... We won't have full visibility until MPL has fully cycled from accrual to cash accounting over the next twelve months.

— Pendal Group, Newsletter, February 2026

Deploying capital into preventative health

Alongside the core insurance business, Medibank has been building out adjacent healthcare assets. Investors Mutual Limited reported in December 2025 that the company acquired Better Medical, a network of 61 medical clinics across Queensland, Victoria, South Australia and Tasmania for $159 million, building on its existing 105-centre primary care business and aligning with a strategy of deploying capital into preventative health that should earn a reasonable standalone return on capital while reducing hospitalisations that benefit the core insurance book. Pendal Group's November 2025 update on the same broader strategy noted Medibank set a new target to grow its Medibank Health division to $200 million in operating profit by FY30, well above consensus forecasts of $126 million, a target the manager said appeared achievable through organic revenue growth around 10 per cent, fixed cost leverage and the maturation of hospital ventures.

If achieved, MPL would have mid-to-high single digit EPS CAGR and a differentiated franchise vs health insurance peers.

— Pendal Group, Monthly Report, November 2025

A defensive holding with a real regulatory risk

Airlie Funds Management's August 2025 commentary captured the balance managers strike with Medibank: the stock had returned around 30 per cent including dividends over the prior twelve months on decent policyholder growth and manageable claims, but the manager flagged that hospital operators themselves were in financial strife and calling on government for support, a genuine source of regulatory risk in an industry that is always subject to policy intervention. Perpetual Asset Management's March 2026 update highlighted the other side of that regulatory relationship, noting the government's approved 5.1 per cent premium increase for the coming year underpins profits, while pointing to the company's push toward at-home post-surgical care as a way of reducing costs for both customers and health providers, even if that shift creates pressure for hospital operators like Ramsay.

What managers are watching next

With Airlie Funds Management holding Medibank within a defensives bucket it has deliberately weighted toward inexpensive names rather than re-rated peers, and Sharpbridge Funds Management naming it among its most bullish bets in May 2026, the key questions for managers are whether the accrual-to-cash accounting transition Pendal Group flagged clarifies the true claims trajectory over the coming year, and whether the Medibank Health division's FY30 profit target and the newly acquired Better Medical clinics deliver the differentiated growth the company is targeting beyond core insurance premiums.